课题基金 / 基金详情

Clarifying the Role of Psychomotor Retardation in Reward-Based Reinforcement Learning Deficits in MDD: A Computational and fMRI Study

Clarifying the Role of Psychomotor Retardation in Reward-Based Reinforcement Learning Deficits in MDD: A Computational and fMRI Study
阐明精神运动迟缓在 MDD 奖励强化学习缺陷中的作用:一项计算和功能磁共振成像研究
批准号:
10591880
负责人:
Allison Letkiewicz
金额:
$18.16万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-12-15 至 2027-11-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Major depressive disorder (MDD) is a highly prevalent and costly mental health disorder. A potentially important contributor to MDD is impaired reward-based reinforcement learning (RBRL). RBRL are a set of processes reflecting difficulty learning which actions are likely to lead to rewarding outcomes, and are clinically significant features of MDD that predicts future depressive symptoms and worse treatment response. MDD, however, is heterogeneous and RBRL may relate to particular MDD symptoms - specifically psychomotor retardation (PmR), a vastly understudied but impairing aspect of MDD that may be especially detrimental for RBRL. Despite overlapping neural circuitry between PmR and RBRL, no study has assessed the impact of PmR on RBRL- related behavior and neural activity in MDD. This is a critical question, as the degree to which RBRL is impaired and which RBRL processes are altered in MDD may depend on PmR. Furthermore, this is highly clinically relevant as ameliorating RBRL deficits related to PmR in MDD may depend on targeting specific RBRL processes. Thus, the overall goal of the proposed K23 is to clarify the role of PmR on RBRL deficits in MDD using innovative computational modeling to parse specific RBRL processes and fMRI. Building on an ongoing R01 (PIs: Dr. Shankman, Mittal, Walther [mentors on this K23]), Aim 1 will test whether experimentally manipulating the demand for psychomotor speed impacts behavioral and neural indicators of RBRL in individuals (ages 18-60) with MDD (N=66) vs. healthy controls (N=44). Aim 2 will test whether a fine-grained laboratory assessment of PmR in MDD predicts behavioral and neural indicators of RBRL, and whether associations between PmR and RBRL are stronger when faster psychomotor speed is required. Aim 3 will examine whether PmR-related RBRL impairment in MDD predicts the course of depression over 1-year. The proposed career development award also aims to provide Dr. Letkiewicz with experiences and training activities that will support her goals of increasing her knowledge of (1) the neural and behavioral basis of psychomotor functioning in MDD, (2) advanced computational modeling to assess reinforcement learning in the context of psychomotor symptoms, (3) multimethod RDoC approaches to studying mechanisms of psychopathology, and (4) grantsmanship and mentorship skills. Her training goals will primarily be accomplished through formal didactics, training with her mentorship team, and the interdisciplinary centers and institutes at Northwestern University. Her mentorship team consists of leading experts in MDD and transdiagnostic research (Dr. Shankman), reinforcement learning and computational modeling (Dr. Kahnt), neuroimaging and motor systems (Dr. Mittal), and psychomotor assessment (Dr. Walther), all of whom have all have active NIH grants and an excellent track record of mentoring early career scientists. This award will prepare Dr. Letkiewicz to submit an R01 grant application and provide her with the skills needed to achieve her long-term career goal of examining the unique and combined contribution of cognitive and motor systems to psychopathology as an independent clinical scientist.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: